1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Infantile Hemangiomas Global Clinical Trials Review, H1, 2014

Infantile Hemangiomas Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Infantile Hemangiomas Global Clinical Trials Review, H1, 2014" provides data on the Infantile Hemangiomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infantile Hemangiomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Infantile Hemangiomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Infantile Hemangiomas Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Infantile Hemangiomas 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Infantile Hemangiomas to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Infantile Hemangiomas to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Infantile Hemangiomas 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Infantile Hemangiomas Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Laboratoires Pierre Fabre SA 31
Clinical Trial Overview of Laboratoires Pierre Fabre SA 31
InfectoPharm Arzneimittel und Consilium GmbH 32
Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 32
Clinical Trial Overview of Top Institutes / Government 33
Instituto Cientifico y Tecnologico de Navarra 33
Clinical Trial Overview of Instituto Cientifico y Tecnologico de Navarra 33
The Children's Hospital of Philadelphia 34
Clinical Trial Overview of The Children's Hospital of Philadelphia 34
The University of Tokyo 35
Clinical Trial Overview of The University of Tokyo 35
Medical College of Wisconsin 36
Clinical Trial Overview of Medical College of Wisconsin 36
Seattle Children's Hospital, Research and Foundation 37
Clinical Trial Overview of Seattle Children's Hospital, Research and Foundation 37
University of Sao Paulo 38
Clinical Trial Overview of University of Sao Paulo 38
The University of Texas Health Science Center at San Antonio 39
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 39
University Hospital, Bordeaux 40
Clinical Trial Overview of University Hospital, Bordeaux 40
The Hospital for Sick Children 41
Clinical Trial Overview of The Hospital for Sick Children 41
Oregon Health and Science University 42
Clinical Trial Overview of Oregon Health and Science University 42
Five Key Clinical Profiles 43
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 67

List of Tables
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Region, 2014* 7
Infantile Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Infantile Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Infantile Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Infantile Hemangiomas Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Infantile Hemangiomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Infantile Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Infantile Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Infantile Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Infantile Hemangiomas Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Infantile Hemangiomas Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Infantile Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 31
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by InfectoPharm Arzneimittel und Consilium GmbH, 2014* 32
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Cientifico y Tecnologico de Navarra, 2014* 33
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2014* 34
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014* 35
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2014* 36
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Children's Hospital, Research and Foundation, 2014* 37
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014* 38
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2014* 39
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014* 40
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 41
Infantile Hemangiomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 42

List of Figures
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Infantile Hemangiomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Infantile Hemangiomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Infantile Hemangiomas Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Infantile Hemangiomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Infantile Hemangiomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Infantile Hemangiomas Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, G7 Countries (%), 2014* 15
Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Infantile Hemangiomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Infantile Hemangiomas to Dermatology Clinical Trials, E7 Countries (%), 2014* 18
Infantile Hemangiomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Infantile Hemangiomas Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Infantile Hemangiomas Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Infantile Hemangiomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Infantile Hemangiomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.